A Case of Tuberculous Arthritis Following the Use of Etanercept

Etanercept is a tumor necrosis factor (TNF) inhibitor that has been used for the treatment of chronic inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Because of its immunosuppressive activity, opportunistic infections have been noted in treated p...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seung Won, Ahn, Jong Joon, Hwang, Young Tae, Koh, Sang Hoon, Cho, Sung Do
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784987/
https://www.ncbi.nlm.nih.gov/pubmed/19949742
http://dx.doi.org/10.3904/kjim.2009.24.4.397
Descripción
Sumario:Etanercept is a tumor necrosis factor (TNF) inhibitor that has been used for the treatment of chronic inflammatory diseases including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Because of its immunosuppressive activity, opportunistic infections have been noted in treated patients, most notably caused by Mycobacterium tuberculosis. Tuberculosis may present in an extrapulmonary or disseminated form. Since TNF-α inhibitors have been used in Korea, a few cases of TNF-α inhibitor associated tuberculosis have been described. However, tuberculous arthritis has not been previously reported. We describe a case of tuberculous arthritis in a 57-year-old woman with rheumatoid arthritis who was treated with etanercept.

Ejemplares similares